75 related articles for article (PubMed ID: 20097209)
1. Inducible nitric oxide synthase-mediated decrease of intestinal P-glycoprotein expression under streptozotocin-induced diabetic conditions.
Nawa A; Fujita Hamabe W; Tokuyama S
Life Sci; 2010 Mar; 86(11-12):402-9. PubMed ID: 20097209
[TBL] [Abstract][Full Text] [Related]
2. [Nitric oxide synthase-mediated alteration of intestinal P-glycoprotein under hyperglycemic stress].
Nawa A; Fujita-Hamabe W; Nakamoto K; Tokuyama S
Yakugaku Zasshi; 2011 Apr; 131(4):487-92. PubMed ID: 21467785
[TBL] [Abstract][Full Text] [Related]
3. Altered intestinal P-glycoprotein expression levels in a monosodium glutamate-induced obese mouse model.
Nawa A; Fujita-Hamabe W; Tokuyama S
Life Sci; 2011 Dec; 89(23-24):834-8. PubMed ID: 21983297
[TBL] [Abstract][Full Text] [Related]
4. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
5. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
[TBL] [Abstract][Full Text] [Related]
6. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression.
Sartoretto JL; Melo GA; Carvalho MH; Nigro D; Passaglia RT; Scavone C; Cuman RK; Fortes ZB
Life Sci; 2005 Oct; 77(21):2676-89. PubMed ID: 15964597
[TBL] [Abstract][Full Text] [Related]
7. Regulatory action of nitric oxide synthase on ileal P-glycoprotein expression under streptozotocin-induced diabetic condition.
Nawa A; Fujita-Hamabe W; Tokuyama S
Biol Pharm Bull; 2011; 34(3):436-8. PubMed ID: 21372399
[TBL] [Abstract][Full Text] [Related]
8. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide mediates increased P-glycoprotein activity in interferon-{gamma}-stimulated human intestinal cells.
Dixit SG; Zingarelli B; Buckley DJ; Buckley AR; Pauletti GM
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G533-40. PubMed ID: 15486347
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
Smith JM; Paulson DJ; Romano FD
J Mol Cell Cardiol; 1997 Sep; 29(9):2393-402. PubMed ID: 9299363
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats.
Nagareddy PR; Xia Z; MacLeod KM; McNeill JH
J Cardiovasc Pharmacol; 2006 Apr; 47(4):513-20. PubMed ID: 16680064
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Paramar AN; Balaraman R
Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
[TBL] [Abstract][Full Text] [Related]
14. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
Schwartz D; Schwartz IF; Blantz RC
J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467
[TBL] [Abstract][Full Text] [Related]
15. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
[TBL] [Abstract][Full Text] [Related]
16. Tubular and glomerular L-arginine transport (uptake and transporters) and the nitric oxide synthases in ischemic acute renal failure (iARF) in streptozotocin-induced diabetic rats (STZ-DM).
Levin-Iaina N; Schwartz I; Chernichovsky T; Davidovitch A; Iaina A; Schwartz D
Ren Fail; 2007; 29(8):1031-8. PubMed ID: 18067052
[TBL] [Abstract][Full Text] [Related]
17. Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats.
Liu H; Xu X; Yang Z; Deng Y; Liu X; Xie L
Brain Res; 2006 Dec; 1123(1):245-52. PubMed ID: 17074306
[TBL] [Abstract][Full Text] [Related]
18. Change in P-glycoprotein and caveolin protein expression in brain striatum capillaries in New Zealand obese mice with type 2 diabetes.
Wu KC; Pan HJ; Yin HS; Chen MR; Lu SC; Lin CJ
Life Sci; 2009 Dec; 85(23-26):775-81. PubMed ID: 19891976
[TBL] [Abstract][Full Text] [Related]
19. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
Wei CL; Hon WM; Lee KH; Khoo HE
Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
[TBL] [Abstract][Full Text] [Related]
20. [Altered intestinal P-glycoprotein expression levels affect pharmacodynamics under diabetic condition].
Nawa A; Fujita-Hamabe W; Kisioka S; Tokuyama S
Yakugaku Zasshi; 2012; 132(2):161-6. PubMed ID: 22293693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
